- Home
- KRO vs OLMA Comparison
KRO vs OLMA Comparison
Compare KRO & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- OLMA
- Stock Information
- Founded
- KRO 1916
- OLMA 2006
- Country
- KRO United States
- OLMA United States
- Employees
- KRO N/A
- OLMA N/A
- Industry
- KRO Major Chemicals
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- KRO Industrials
- OLMA Health Care
- Exchange
- KRO Nasdaq
- OLMA Nasdaq
- Market Cap
- KRO 598.2M
- OLMA 560.7M
- IPO Year
- KRO N/A
- OLMA 2020
- Fundamental
- Price
- KRO $5.74
- OLMA $11.10
- Analyst Decision
- KRO Strong Sell
- OLMA Strong Buy
- Analyst Count
- KRO 2
- OLMA 5
- Target Price
- KRO $7.75
- OLMA $24.00
- AVG Volume (30 Days)
- KRO 333.7K
- OLMA 1.2M
- Earning Date
- KRO 11-05-2025
- OLMA 11-11-2025
- Dividend Yield
- KRO 3.50%
- OLMA N/A
- EPS Growth
- KRO 3452.79
- OLMA N/A
- EPS
- KRO 0.59
- OLMA N/A
- Revenue
- KRO $1,892,000,000.00
- OLMA N/A
- Revenue This Year
- KRO $4.87
- OLMA N/A
- Revenue Next Year
- KRO $8.34
- OLMA N/A
- P/E Ratio
- KRO $9.75
- OLMA N/A
- Revenue Growth
- KRO 6.51
- OLMA N/A
- 52 Week Low
- KRO $4.70
- OLMA $2.86
- 52 Week High
- KRO $12.98
- OLMA $13.51
- Technical
- Relative Strength Index (RSI)
- KRO 44.29
- OLMA 77.80
- Support Level
- KRO $5.56
- OLMA $8.01
- Resistance Level
- KRO $5.80
- OLMA $11.50
- Average True Range (ATR)
- KRO 0.23
- OLMA 0.78
- MACD
- KRO -0.04
- OLMA 0.22
- Stochastic Oscillator
- KRO 22.22
- OLMA 88.57
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.